Age and treatment disparities in survival of primary malignant cardiac tumors: an analysis of over 40 years and 500 patients.

ABSTRACT:

Background

Primary malignant cardiac tumors (PMCTs) are rare and tend to have a poor prognosis, due to their aggressive biological behavior and the inadequate expertise with the disease. This article compares the survival of patients with PMCT subtypes in the United States across age and treatment groups.

Methods

Data of 529 patients diagnosed with PMCTs were analyzed. Chi-squared test was used to assess significance of the differences between proportions in demographic and tumor characteristics by age and treatment. Cox regression analysis was used to estimate survival from the Surveillance, Epidemiology, and End Results (SEER) follow-up data.

Results

Survival rates for PMCTs differed significantly between age groups, with patients younger than 20 years surviving sign

SUBMITTER: Wang W 

PROVIDER: S-EPMC10482641 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature